Vitura Health doubles profit with shareholders set for second dividend, but shares dip 10% by Steve Jones August 23, 2023April 30, 2024 Vitura Health’s share price fell 10% yesterday despite posting a year-end after tax profit of A$13.8 […]
CanView sets sights on 2023 milestone as sales continue to rise by Steve Jones June 13, 2023April 30, 2024
Releaf Group to get own version of CanView in tie-up with Vitura Health by Steve Jones May 16, 2023April 30, 2024
Vitura Health forms JV to distribute and manufacture MDMA and psilocybin in Australia by Steve Jones May 2, 2023April 30, 2024
Company news: Vitura Health; Puro; MGC Pharma; Incannex; Cann Global by Steve Jones March 8, 2023April 30, 2024
Vitura Health relishes competition as firm begins ‘phase two’ of growth plan by Steve Jones February 16, 2023April 30, 2024
Vitura Health reports record half as CanView continues to thrive by Martin Lane February 13, 2023February 13, 2023
Cronos Australia ditches pre-merger past with rebrand to Vitura Health by Steve Jones February 6, 2023April 29, 2024
Cronos Australia ditches face-to-face consultations with closure of physical clinics by Steve Jones January 16, 2023April 29, 2024
Cronos hits 1m product milestone as revenues continue to rise by Steve Jones December 5, 2022April 29, 2024
